Links to various Aetna Better Health and non-Aetna Better Health sites are provided for your convenience. Aetna Better Health of California is not responsible or liable for non-Aetna Better Health content, accuracy or privacy practices of linked sites or for products or services described on these sites.
November 2023
2023 Immunization Update: COVID-19, Influenza, RSV, HepB, Pneumococcal, HPV, Polio, Mpox, and MMR
August 2023
No Added Benefit from Concomitant Use of GLP-1 Agonists and DPP-4 Inhibitors (PDF)
New Resources Available for Perinatal Mental Health Conditions (PDF)
June 2023
FDA Approves First Over-the-Counter Naloxone Nasal Spray (PDF)
Updated Guidance by the CDC and FDA for Prescribing Opioids (PDF)
May 2023
Clinical Review: Management of Acute Postpartum Pain (PDF)
January 2023
2022 Immunization Update: Mpox, HepB, Influenza, COVID-19, Pneumococcal, Zoster (PDF)
Improving the Quality of Care: Treatment of Latent Tuberculosis Infection (PDF)
Risks to Patients Exposed to Xylazine in Illicit Drugs (PDF)
Removal of DATA-Waiver (X-Waiver) Requirement (PDF)
May 2022
Submitting Quality Data to the California Immunization Registry (CAIR2) (PDF)
March 2022
Improving the Quality of Care: Legislative Impact on the Use of Naloxone (PDF)
February 2022
Professional Organizations Push for Recall of Buprenorphine Dental Warning (PDF)
September 2021
2021 Immunization Updates: COVID-19, Influenza, and Meningococcal Disease (PDF)
August 2021
Drug Safety Communication: FDA Requests Removal of Pregnancy Contraindication for Statins (PDF)
April 2021
Drug Safety Communication: Potential Increased Arrhythmia Risk from Lamotrigine (PDF)
March 2021
Clinical Review: Recommendations for the Tapering of Benzodiazepines (PDF)
January 2021
Clinical Review: Recommendations for the Management of Acute Dental Pain (PDF)
August 2020
Clinical Review: 2020 Standards of Care for Treatment of Type 2 Diabetes (PDF)
August 2019
CDC, ACIP release flu vaccine recommendations for upcoming flu season (PDF)
CDC, ACIP release human papillomavirus vaccination for adults: updated recommendations (PDF)
July 2019
CDC releases interim infection prevention and control recommendations for measles
California drug take-back program
Accelerating opioid safety: ambulatory care toolkit (PDF)
July 2018
Drug safety communication: adverse effects from fluoroquinolone antibiotics (PDF)
March 2018
In the pharmacy: pharmacists furnishing nicotine replacement products (PDF)
February 2018
Drug safety communication: new age limit for opioid cough and cold medicines (PDF)
September 2017
Alert: online report to the Vaccine Adverse Event Reporting System (VAERS) (PDF)
2017 immunization updates: influenza, HepA, meningococcal, HPV, adult vaccines (PDF)
June 2023
Treating Depression in Primary Care (2023) (PDF)
May 2023
Effects of Medication Adherence (PDF)
March 2023
2023 GOLD Report Pharmacological Updates (PDF)
February 2023
Clinical Practice Guidelines for Obesity (PDF)
January 2023
The Updated 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain (PDF)
September 2022
Insulin Biosimilars, Follow-Ons, and Authorized Generics (PDF)
Assuring the Safe Use of Melatonin in Children (PDF)
January 2022
Rare but significant risk of Diabetic Ketoacidosis associated with SGLT2 inhibitors (PDF)
Metabolic Monitoring for Children and Adolescents on Antipsychotics (PDF)